David M. Stresser
AbbVie (United States)(US)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, Computational Drug Discovery Methods, Eicosanoids and Hypertension Pharmacology, Analytical Chemistry and Chromatography
Most-Cited Works
- → Substrate-Dependent Modulation of CYP3A4 Catalytic Activity: Analysis of 27 Test Compounds with Four Fluorometric Substrates(2000)273 cited
- → Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity(1999)272 cited
- → Cytochrome P450 Fluorometric Substrates: Identification of Isoform-Selective Probes for Rat CYP2D2 and Human CYP3A4.(2002)162 cited
- → In vitro and pharmacophore insights into CYP3A enzymes(2003)150 cited
- → A High-Throughput Screen to Identify Inhibitors of Aromatase (CYP19)(2000)138 cited
- → HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE(2004)128 cited
- → Monospecific Antipeptide Antibody to Cytochrome P-450 2B6(1999)113 cited
- → In Vitro Drug Metabolism Using Liver Microsomes(2016)107 cited
- → Fluorometric screening for metabolism-based drug–drug interactions(2000)100 cited
- → Indole-3-carbinol and beta-naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat.(1994)97 cited